Monoclonal Antibody Therapeutics (mABs) Market: Growth, Segmentation, and Future Outlook (2025–2031)
The monoclonal antibody therapeutics (mABs) market has emerged as a cornerstone of modern biopharmaceutical innovation, driven by the rising prevalence of chronic diseases such as cancer, autoimmune disorders, and infectious conditions. Monoclonal antibodies are engineered proteins designed to bind to specific antigens, enabling targeted therapy with high precision and reduced side effects...
0 Comments 0 Shares 5 Views 0 Reviews